分子遗传病理学进展对特定头颈部软组织肿瘤分类、诊断及治疗的影响
The impact of advances in molecular genetic pathology on the classification, diagnosis and treatment of selected soft tissue tumors of the head and neck.
作者信息
García Joaquín J, Folpe Andrew L
机构信息
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st St. SW, Rochester, MN, USA.
出版信息
Head Neck Pathol. 2010 Mar;4(1):70-6. doi: 10.1007/s12105-009-0160-z. Epub 2010 Jan 22.
Abstract
Recent advances in molecular pathology have had a significant impact on the diagnosis, classification, and treatment of soft tissue tumors. The practical application of these discoveries promises to assist greatly in the evaluation and treatment of soft tissue neoplasms in the head and neck region-an area characterized by exceedingly complex anatomy that often restricts the ample sampling of lesions and complete surgical resection. This reviews details some ways in which molecular techniques have strengthened conventional diagnostic and management approaches to low-grade fibromyxoid sarcoma, angiomatoid (malignant) fibrous histiocytoma, and dermatofibrosarcoma protuberans, all of which may involve the head and neck region.
摘要
分子病理学的最新进展对软组织肿瘤的诊断、分类和治疗产生了重大影响。这些发现的实际应用有望极大地帮助评估和治疗头颈部区域的软组织肿瘤，该区域解剖结构极其复杂，常常限制了对病变的充分取材和完整的手术切除。本文综述详细介绍了分子技术在哪些方面加强了对低度纤维黏液样肉瘤、血管瘤样（恶性）纤维组织细胞瘤和隆突性皮肤纤维肉瘤的传统诊断和管理方法，所有这些肿瘤都可能累及头颈部区域。
相似文献
1
The impact of advances in molecular genetic pathology on the classification, diagnosis and treatment of selected soft tissue tumors of the head and neck.分子遗传病理学进展对特定头颈部软组织肿瘤分类、诊断及治疗的影响
Head Neck Pathol. 2010 Mar;4(1):70-6. doi: 10.1007/s12105-009-0160-z. Epub 2010 Jan 22.
2
[Fibrohistiocytic tumors of the skin: a heterogeneous group of superficially located mesenchymal neoplasms].[皮肤纤维组织细胞肿瘤：一组位于浅表的异质性间叶性肿瘤]
Pathologe. 2015 Feb;36(1):79-88. doi: 10.1007/s00292-014-2032-x.
3
Cutaneous soft tissue tumors: how do we make sense of fibrous and "fibrohistiocytic" tumors with confusing names and similar appearances?皮肤软组织肿瘤：对于那些名称混淆、外观相似的纤维性及“纤维组织细胞性”肿瘤，我们该如何明辨？
Mod Pathol. 2020 Jan;33(Suppl 1):56-65. doi: 10.1038/s41379-019-0388-4. Epub 2019 Oct 25.
4
Head and neck soft tissue sarcomas: a multivariate analysis of outcomes.头颈部软组织肉瘤：结局的多变量分析
Ann Surg Oncol. 2004 Jun;11(6):619-28. doi: 10.1245/ASO.2004.03.006.
5
Cutaneous and subcutaneous fibrohistiocytic tumors of intermediate malignancy: an update.中度恶性皮肤和皮下纤维组织细胞肿瘤：最新进展
Am J Dermatopathol. 2004 Apr;26(2):141-55. doi: 10.1097/00000372-200404000-00035.
6
Malignant fibrous histiocytoma of the head and neck. Case report.头颈部恶性纤维组织细胞瘤。病例报告。
Bull Group Int Rech Sci Stomatol Odontol. 1995 Sep-Oct;38(3-4):121-4.
7
Cellular fibrous histiocytoma of the skin: evidence of a clonal process with different karyotype from dermatofibrosarcoma.皮肤细胞性纤维组织细胞瘤：与皮肤纤维肉瘤不同核型的克隆性过程的证据。
Genes Chromosomes Cancer. 1997 Apr;18(4):314-7. doi: 10.1002/(sici)1098-2264(199704)18:4<314::aid-gcc11>3.0.co;2-g.
8
Uncommon cutaneous neoplasms of the head and neck.头颈部罕见皮肤肿瘤
Facial Plast Surg Clin North Am. 2012 Nov;20(4):483-91. doi: 10.1016/j.fsc.2012.08.002.
9
Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms.皮肤间叶性肿瘤在诊断、分类及分子发病机制方面的最新进展
Histopathology. 2022 Jan;80(1):216-232. doi: 10.1111/his.14450.
10
Fibrosarcoma of the head and neck.头颈部纤维肉瘤
Laryngoscope. 1990 Aug;100(8):799-802. doi: 10.1288/00005537-199008000-00001.
引用本文的文献
1
Intracranial angiomatoid fibrous histiocytoma: report of a rare case.颅内血管样纤维组织细胞瘤：1例罕见病例报告
Iran J Child Neurol. 2022 Summer;16(3):205-212. doi: 10.22037/ijcn.v15i4.26805. Epub 2022 Jul 16.
2
Head and neck sarcoma: three-year data from a tertiary referral centre.头颈部肉瘤：来自一家三级转诊中心的三年数据。
Ann R Coll Surg Engl. 2021 Nov;103(10):762-767. doi: 10.1308/rcsann.2021.0119. Epub 2021 Aug 27.
3
CORR Insights: Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma.CORR 见解：在患有血管瘤样纤维组织细胞瘤的患者中，病理上良性的淋巴结在影像学上可模仿恶性肿瘤。
Clin Orthop Relat Res. 2017 Sep;475(9):2280-2282. doi: 10.1007/s11999-017-5426-2. Epub 2017 Jun 27.
4
Retroperitoneal angiomatoid fibrous histiocytoma: A case report and review of the literature.腹膜后血管样纤维组织细胞瘤：一例报告并文献复习
Oncol Lett. 2013 Jun;5(6):1833-1835. doi: 10.3892/ol.2013.1273. Epub 2013 Mar 27.
本文引用的文献
1
EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma.血管样纤维组织细胞瘤中的EWSR1-CREB1和EWSR1-ATF1融合基因。
Clin Cancer Res. 2007 Dec 15;13(24):7322-8. doi: 10.1158/1078-0432.CCR-07-1744.
2
EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma.EWSR1-CREB1是血管样纤维组织细胞瘤中主要的基因融合。
Genes Chromosomes Cancer. 2007 Dec;46(12):1051-60. doi: 10.1002/gcc.20491.
3
Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.易位阳性低级别纤维黏液样肉瘤：一项来自法国肉瘤研究组的研究，对一系列病例进行临床病理及分子分析，扩展了形态学谱并提示其与硬化性上皮样纤维肉瘤的潜在关系
Am J Surg Pathol. 2007 Sep;31(9):1387-402. doi: 10.1097/PAS.0b013e3180321959.
4
Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera.天然CREB3L2转录因子和FUS/CREB3L2嵌合体的表征
Genes Chromosomes Cancer. 2007 Feb;46(2):181-91. doi: 10.1002/gcc.20395.
5
EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation.EWS-CREB1：透明细胞肉瘤中一种复发性变异融合基因——与胃肠道定位及无黑素细胞分化相关
Clin Cancer Res. 2006 Sep 15;12(18):5356-62. doi: 10.1158/1078-0432.CCR-05-2811.
6
Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.使用福尔马林固定、石蜡包埋组织标本对低度纤维黏液样肉瘤中FUS-CREB3L2融合转录本进行分子检测。
Am J Surg Pathol. 2006 Sep;30(9):1077-84. doi: 10.1097/01.pas.0000209830.24230.1f.
7
The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤中纤维肉瘤样转化的预后意义。
Am J Surg Pathol. 2006 Apr;30(4):436-43. doi: 10.1097/00000478-200604000-00002.
8
Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate.甲磺酸伊马替尼使转移性隆突性皮肤纤维肉瘤持续完全缓解。
Anticancer Drugs. 2005 Apr;16(4):461-6. doi: 10.1097/00001813-200504000-00014.
9
Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.低度恶性纤维黏液样肉瘤的临床病理及分子遗传学特征，以及一种新型FUS/CREB3L1融合基因的克隆
Lab Invest. 2005 Mar;85(3):408-15. doi: 10.1038/labinvest.3700230.
10
The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.嵌合型FUS/CREB3l2基因是低度恶性纤维黏液样肉瘤所特有的。
Genes Chromosomes Cancer. 2004 Jul;40(3):218-28. doi: 10.1002/gcc.20037.
Zotero 插件